Lessons learned from HIV-1 vaccine trials: New priorities and directions

Nature Immunology

Volumn 13, Issue 5, 2012, Pages 423-427

  McMichael, Andrew J ^a   Haynes, Barton F ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY BLOOD LEVEL; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DRUG ABUSE; DRUG DESIGN; DRUG EFFICACY; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INFECTION RISK; NONHUMAN; NOTE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THAILAND;

AIDS VACCINES; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLINICAL TRIALS AS TOPIC; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MACACA MULATTA; T-LYMPHOCYTES;

EID: 84859919465     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2264     Document Type: Note

References (66)

1. Gilbert, P.B. et al. J. Infect. Dis. 191, 666-677 (2005).
2. Pitisuttithum, P. et al. J. Infect. Dis. 194, 1661-1671 (2006).
3. Buchbinder, S.P. et al. Lancet 372, 1881-1893 (2008).
4. Rerks-Ngarm, S. et al. N. Engl. J. Med. 361, 2209-2220 (2009).
5. Kim, J.H., Rerks-Ngarm, S., Excler, J.L. & Michael, N.L. Curr. Opin. HIV AIDS 5, 428-434 (2010).
6. Cohen, J. Science 326, 652-653 (2009).
7. Gilbert, P.B. et al. J. Infect. Dis. 203, 969-975 (2011).
8. Montefiori, D. et al. J. Infect. Dis. (in the press) (2012).
9. Haynes, B.F. Case control study of the RV144 trial for immune correlates: the analysis and was forward. AIDS Vaccine Conference 2011 (Bangkok, Thailand, September 12-15, 2011).
10. Price, M.A. et al. J. Acquir. Immune Defic. Syndr. 59, 185-193 (2012).
11. Keele, B.F. et al. Proc. Natl. Acad. Sci. USA 105, 7552-7557 (2008).
12. Forthal, D.N., Gilbert, P.B., Landucci, G. & Phan, T. J. Immunol. 178, 6596-6603 (2007).
13. Dinges, W.L. et al. J. Virol. 84, 4461-4468 (2010).
14. Burton, D.R. & Weiss, R.A. Science 329, 770-773 (2010).
15. McMichael, A.J., Borrow, P., Tomaras, G.D., Goonetilleke, N. & Haynes, B.F. Nat. Rev. Immunol. 10, 11-23 (2010).
16. Verkoczy, L., Kelsoe, G., Moody, M.A. & Haynes, B.F. Curr. Opin. Immunol. 23, 383-390 (2011).
17. Wardemann, H. et al. Science 301, 1374-1377 (2003).
18. Wrammert, J. et al. Nature 453, 667-671 (2008).
19. Scheid, J.F. et al. Science 333, 1633-1637 (2011).
20. Morris, L. et al. PLoS ONE 6, e23532 (2011).
21. Wu, X. et al. Science 329, 856-861 (2010).
22. Verkoczy, L. et al. J. Immunol. 187, 3785-3797 (2011).
23. Verkoczy, L. et al. Proc. Natl. Acad. Sci. USA 107, 181-186 (2010).
24. Pejchal, R. et al. Science 334, 1097-1103 (2011).
25. Chen, L. et al. Science 326, 1123-1127 (2009).
26. McLellan, J.S. et al. Nature 480, 336-343 (2011).
27. Wu, X. et al. Science 333, 1593-1602 (2011).
28. Zhou, T. et al. Science 329, 811-817 (2010).
29. Gray, E.S. et al. J. Virol. 85, 4828-4840 (2011).
30. Diskin, R. et al. Science 334, 1289-1293 (2011).
31. Mouquet, H. et al. Nature 467, 591-595 (2010).
32. Walker, L.M. et al. Nature 477, 466-470 (2011).
33. Bonsignori, M. et al. J. Virol. 85, 9998-10009 (2011).
34. Corti, D. et al. PLoS ONE 5, e8805 (2010).
35. Bonsignori, M. et al. J. Virol. published online, doi:10.1128/JVI.07163- 11 (1 February 2012).
36. Balazs, A.B. et al. Nature 481, 81-84 (2011).
37. Haynes, B.F. et al. Science 308, 1906-1908 (2005).
38. Alam, S.M. et al. J. Virol. 85, 11725-11731 (2011).
39. Xiao, X. et al. Biochem. Biophys. Res. Commun. 390, 404-409 (2009).
40. Liao, H.X. et al. J. Exp. Med. 208, 2237-2249 (2011).
41. Ma, B.J. et al. PLoS Pathog. 7, e1002200 (2011).
42. Shih, T.A., Meffre, E., Roederer, M. & Nussenzweig, M.C. Nat. Immunol. 3, 570-575 (2002).
43. Haynes, B. et al. Nat. Biotechnol. (in the press) (2012).
44. Johnson, P.R. et al. Nat. Med. 15, 901-906 (2009).
45. McElrath, M.J. et al. Lancet 372, 1894-1905 (2008).
46. Duerr, A. et al. J. Infect. Dis. (in the press) (2012).
47. Rolland, M. et al. Nat. Med. 17, 366-371 (2011).
48. Liu, J. et al. Nature 457, 87-91 (2009).
49. Hansen, S.G. et al. Nature 473, 523-527 (2011).
50. Barouch, D.H. et al. Nature 482, 89-93 (2012).
51. Lee, J.K. et al. J. Exp. Med. 200, 1455-1466 (2004).
52. Ferrari, G. et al. PLoS Pathog. 7, e1001273 (2011).
53. Létourneau, S. et al. PLoS ONE 2, e984 (2007).
54. Rolland, M., Nickle, D.C. & Mullins, J.I. PLoS Pathog. 3, e157 (2007).
55. Mothe, B. et al. J. Transl. Med. 9, 208 (2011).
56. Korber, B.T., Letvin, N.L. & Haynes, B.F. J. Virol. 83, 8300-8314 (2009).
57. Santra, S. et al. Nat. Med. 16, 324-328 (2010).
58. Barouch, D.H. et al. Nat. Med. 16, 319-323 (2010).
59. Burton, D.R. et al. Proc. Natl. Acad. Sci. USA 108, 11181-11186 (2011).
60. Sun, J.C., Beilke, J.N. & Lanier, L.L. Nature 457, 557-561 (2009).
61. Gillard, G.O. et al. PLoS Pathog. 7, e1002141 (2011).
62. Mureithi, M.W. et al. AIDS Res. Hum. Retroviruses 27, 501-509 (2011).
63. Favre, D., et al. Sci. Transl. Med. 2, 32ra36 (2010).
64. Elahi, S. et al. Nat. Med. 17, 989-995 (2011).
65. Brenchley, J.M. et al. Blood 112, 2826-2835 (2008).
66. Estes, J.D. et al. PLoS Pathog. 6, e1001052 (2010).